The Daily The Promise and Peril of Vaping, Part 2: The Story of Juul
Oct 30, 2019
Sheila Kaplan, an investigative reporter for The New York Times, delves into the creation and impact of Juul, a modern e-cigarette marketed as a solution for smokers. She discusses Juul's explosive rise fueled by innovative marketing tactics aimed at both smokers and youth. Kaplan reveals the controversial partnership between Juul and Altria, which raised questions about public health commitment. She also highlights the alarming surge in vaping-related illnesses among adolescents, emphasizing the urgent need for regulatory action.
AI Snips
Chapters
Transcript
Episode notes
Juul's Origin
- Juul's story began around 2007 at Stanford University with two design students, James Monsees and Adam Bowen.
- They aimed to create a healthier alternative to existing nicotine cessation products.
FDA's Initial Stance
- The FDA's initial enthusiasm for Juul stemmed from the hope that it could be a more appealing alternative to smoking.
- The agency granted Juul five years to prove its health claims, allowing it to remain on the market.
Marketing and Growth
- Juul's marketing, featuring celebrities and influencers, focused on the product's coolness, not quitting smoking.
- This strategy led to rapid growth and market dominance, with Juul becoming synonymous with vaping.